USPTO serial 79357619
1 SURVEY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 9, 2024
- Examiner
- HINES, REGINA C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with 1 SURVEY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; Downloadable computer application software for mobile phones, tablets, handheld computers, namely, software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; downloadable specialized software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; downloadable collaborative software, namely software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; Downloadable communication software to access data stored on an oximeter and transfer data to another device; downloadable file sharing software; downloadable document management software; downloadable software for management of data, files and databases; downloadable software for process control of Quality Management Systems (QMS); downloadable data processing software; downloadable computer software for managing the product life cycles of others; downloadable industrial process management software; downloadable software for production process monitoring, analysis, control and operation of medical devices, scientific equipment, clinical trials; downloadable software for verification of the regulatory compliance of goods; downloadable software for monitoring the regulatory compliance of clinical trials; downloadable software for quality control in the field of medical devices and the pharmaceutical industry; downloadable software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials | ACTIVE | — |
| 038 | Providing access to and rental of access time to a database of third parties; providing access to data or documents in electronic format on centralized files for remote consultation; providing online access to platforms and portals on the Internet; electronic transmission of messages, data and documents | ACTIVE | — |
| 042 | Website hosting services; software as a service (SAAS) services, namely, software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; rental of computer software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; development, programming and implementation of computer software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; development, programming and implementation of data processing software; development, programming and implementation of software for checking the regulatory compliance of goods; development, programming and implementation of software for quality control of goods and clinical studies; quality control consultation services for others; analysis and assessment of product design in the field of medical devices and the pharmaceutical industry; non-downloadable computer software used to perform qualitative assessment of the performance of pharmaceuticals, medical products and medical devices; providing information on product development for others; non- downloadable computer software used to perform preliminary assessment services in the field of new pharmaceuticals, medical products and medical devices; pharmaceutical research and development consultation services; consultation services on product development of others in the field of medical devices and the pharmaceutical industry; providing information on the results of product development clinical trials for pharmaceuticals, medical products and medical devices; design and development of medical technologies for others; design and development of analytical methods and tests for others; research and development services in the field of medical devices and pharmaceuticals; scientific and technological design services; conducting of scientific feasibility studies for others; conducting technical feasibility studies for others; conducting scientific feasibility studies with respect to product design; conducting scientific feasibility studies with respect to the analysis of materials in the field of medical devices, pharmaceuticals, parapharmaceuticals; conducting scientific feasibility studies in the field of clinical trials; planning and conducting scientific pre-clinical and clinical studies; providing medical and scientific research information of pharmaceuticals and clinical trials; conducting scientific clinical trials and research for third parties; conducting clinical trials for others in the field of pharmaceuticals, medical products and medical apparatus; providing scientific research information in the field of clinical trials; pharmaceutical research and development; research of technical projects in the field of medical devices and the pharmaceutical industry; assessment of chemical information in relation to risks; assessment of toxicological information in relation to risks; development of customized software for others for use in risk assessment in the field of medical devices and the pharmaceutical industry; development of customized software for others for the scientific assessment of risks; analytical laboratory services; laboratory research services relating to pharmaceuticals, medical devices and medical products; scientific laboratory services; advisory services with respect to laboratory tests; diagnostic services for others for scientific research purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by 1MED SA
- Other trademarks owned by 1MED SA
- Other trademarks owned by 1MED SA
- Other trademarks in Class 009
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named 1 SURVEY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 7, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 7, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 7, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 14, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 14, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 9, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 15, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 15, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 23, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 3, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 3, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 21, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 20, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 20, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 7, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 7, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 1, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 1, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 30, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |